Original language | English |
---|---|
Pages (from-to) | 695-698 |
Number of pages | 4 |
Journal | Journal of Clinical Immunology |
Volume | 42 |
Issue number | 3 |
DOIs | |
Publication status | Published - Apr 2022 |
Bibliographical note
Funding Information:PMH has received grants and research support from Takeda, CSL Behring, Abbvie, Lamepro, Novartis Nederland, and honoraria or consultation fees from UCB Pharma. The other authors declare no competing interests.
Funding Information:
This study was funded by the H2020 EU MOODSTRATIFICATION project (grant agreement number 754740).